Multiple sclerosis (MS) is an autoimmune disease that causes mild to severe issues in the central nervous system (CNS). Early detection and treatment are necessary to reduce the harshness of the disease in individuals. The proposed work aims to implement a convolutional neural network (CNN) segmentation scheme to extract the MS lesion in a 2D brain MRI slice. To achieve a better MS detection, this work implemented the VGG-UNet scheme in which the pretrained VGG19 is considered as the encoder section. This scheme is tested on 30 patient images (600 images with dimension 512 × 512 × 3 pixels), and the experimental outcome confirms that this scheme provides a better result compared to traditional UNet, SegNet, VGG-UNet, and VGG-SegNet. The experimental investigation implemented on axial, coronal and sagittal plane 2D slices of Flair modality confirms that this work provides a better value of Jaccard (>85%), Dice (>92%), and accuracy (>98%).

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184172PMC
http://dx.doi.org/10.1155/2022/4928096DOI Listing

Publication Analysis

Top Keywords

multiple sclerosis
8
framework segment
4
segment evaluate
4
evaluate multiple
4
sclerosis lesion
4
lesion mri
4
mri slices
4
slices vgg-unet
4
vgg-unet multiple
4
sclerosis autoimmune
4

Similar Publications

Multiple sclerosis (MS) is a common autoimmune disease that primarily affects young adults. In this condition, the immune system attacks the myelin sheath of nerve cells, leading to a variety of neurological symptoms. MS diagnosis often relies on the analysis of oligoclonal bands (OCBs), which involves detecting oligoclonal immunoglobulin G (IgG) bands in cerebrospinal fluid (CSF) and serum.

View Article and Find Full Text PDF

Single-cell transcriptomics applied to cerebrospinal fluid (CSF) for elucidating the pathophysiology of neurologic diseases has produced only a preliminary characterization of CSF immune cells. CSF derives from and borders central nervous system (CNS) tissue, allowing for comprehensive accounting of cell types along with their relative abundance and immunologic profiles relevant to CNS diseases. Using integration techniques applied to publicly available datasets in combination with our own studies, we generated a compendium with 139 subjects encompassing 135 CSF and 58 blood samples.

View Article and Find Full Text PDF

Brain organoid methodologies to explore mechanisms of disease in progressive multiple sclerosis.

Front Cell Neurosci

December 2024

Department of Clinical Neurosciences and NIHR Biomedical Research Centre, University of Cambridge, Cambridge, United Kingdom.

Multiple sclerosis (MS), a debilitating autoimmune disorder targeting the central nervous system (CNS), is marked by relentless demyelination and inflammation. Clinically, it presents in three distinct forms: relapsing-remitting MS (RRMS), primary progressive MS (PPMS), and secondary progressive MS (SPMS). While disease-modifying therapies (DMTs) offer some relief to people with RRMS, treatment options for progressive MS (pMS) remain frustratingly inadequate.

View Article and Find Full Text PDF

Multiple sclerosis (MS) predominantly affects women of childbearing age, significantly impacting their quality of life (QOL). The diagnosis of MS can influence pregnancy intention, and the level of disability associated with MS may change before and after pregnancy. This study aims to analyze the reproductive characteristics of Iranian female patients with MS (PwMS) and their association with the Expanded Disability Status Scale (EDSS) and pregnancy tendency, providing valuable insights into disease progression and the development of tailored treatments.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!